Mabwell (Shanghai) Bioscience Co., Ltd. (Ticker: 2493 HK) is a Chinese biotechnology company focusing on the research, development, manufacturing, and distribution of biologic drugs. Mabwell plans to list on the Hong Kong Stock Exchange on April 28, 2026, planning to offer 47.13 million shares at an expected price range of HKD 27.64 to HKD 30.71, raising HKD 1.45 billion (USD 184.83 million).

According to the prospectus, the company specializes in therapies for oncology, immunology, ophthalmology, and orthopedics. Its pipeline includes monoclonal antibodies, biosimilars, and a core Nectin-4 targeting antibody-drug conjugate currently in multiple clinical trials. The upcoming listing is structured as an H Share issuance, which will complement the company's existing A Shares already listed on the Shanghai Stock Exchange STAR Market.

As reported in the published terms, Mabwell plans to use the IPO proceeds primarily for research and development, enhancing product capacity, brand promotion, and business development. Additional funds are earmarked for working capital, strategic acquisitions, and other general corporate purposes. Reportedly, the joint sponsors and underwriters managing the offering include Haitong International Capital, CITIC Securities, and ABCI Capital.

Shanghai Xizhi Technology Co., Ltd. (Ticker: 1879 HK) is a Chinese company specializing in advanced optoelectronic computing services and solutions. Shanghai Xizhi Technology plans to list on the Hong Kong Stock Exchange on April 28, 2026, planning to offer 13.80 million shares at an expected price range of HKD 166.60 to HKD 183.20, raising HKD 2.53 billion (USD 322.73 million). Based on the offering details, the implied market capitalization is expected to range from approximately USD 1.95 billion to USD 2.15 billion.

According to the prospectus, the company focuses on optical interconnect and optical computing, leveraging proprietary chip technologies to deliver low-latency, high-throughput systems designed for artificial intelligence infrastructure. As reported in the published terms, Shanghai Xizhi Technology plans to use the IPO proceeds primarily for research and development and expanding product capacity. Additional funds will reportedly be allocated toward brand promotion, business development, working capital, and strategic acquisitions. The corporate structure for the listing involves an H Share issuance. According to sources, the underwriters managing the offering include China International Capital Corporation, Haitong International Securities, and HSBC.

X-Energy, Inc. (Ticker: XE US) is a United States-based company developing advanced small modular nuclear reactors and proprietary fuel technology for clean energy generation. X-Energy plans to list on the NASDAQ on April 24, 2026, planning to offer 42,857,143 primary shares at an estimated price range of $16.00 to $19.00 per share, raising an estimated total of approximately $750 million.

According to the provided business description, the company aims to redefine the nuclear energy industry. Its simplified, modular, and intrinsically safe reactor design is intended to expand the applications and markets for the deployment of nuclear technology. The company focuses on delivering clean, safe, and reliable energy that meets modern economic demands, while reportedly driving enhanced safety, lower costs, and faster construction timelines compared to conventional nuclear facilities and other small modular reactors.

The IPO is being led by a syndicate of underwriters, with J.P. Morgan, Morgan Stanley, Jefferies, and Moelis acting as joint bookrunners. Furthermore, J.P. Morgan is reportedly serving as the stabilization agent and handling the bill and deliver process for the offering.

The Elmet Group Co. (Ticker: ELMT US) is a United States-based company specializing in precision-engineered critical components and advanced high-energy systems. The Elmet Group plans to list on the NASDAQ on April 23, 2026, planning to offer 7.69 million shares at a price range of $12.00 to $14.00 per share, raising an estimated $100.0 million. The company has a reported market capitalization of $363.6 million.

According to filings, the company operates through two primary divisions: Critical Materials Components (CMC) and Engineered Microwave Products (EMP). Reportedly, following a reorganization in January 2026, the company conducts its business through two primary operating subsidiaries: Elmet Technologies LLC and Microwave Techniques LLC. The company focuses on manufacturing components from critical materials such as tungsten and molybdenum, as well as high-power microwave systems for various industries including the aerospace, defense, semiconductor, and medical sectors. The IPO is being managed by a syndicate of underwriters, with Cantor, Needham & Co., Canaccord Genuity, and Roth Capital Partners acting as joint managers.

Huaqin Co Ltd (Ticker: 3296 HK) is a Chinese company specializing in smart products and serving as a comprehensive Original Design Manufacturer platform. Huaqin plans to list on the Hong Kong Stock Exchange on April 23, 2026, planning to offer 58.55 million shares at an expected price of HKD 77.70, raising HKD 4.55 billion (USD 580.70 million).

According to the prospectus, the company integrates core technologies, including AI, IoT, and cloud computing, to provide global technology brands with diverse devices ranging from smartphones and tablets to servers and smart wearables.

As reported in the published terms, Huaqin plans to use the IPO proceeds primarily for research and development and product capacity enhancements, accounting for 40 percent of the funds. An additional 35 percent is earmarked for brand promotion and business development, while the remaining 25 percent will be directed toward working capital and strategic acquisitions. The offering is structured as an H Share issuance for the global market. Reportedly, the underwriters of the offering include major institutions such as China International Capital Corporation, Goldman Sachs, and Merrill Lynch, alongside substantial backing from institutional cornerstone investors.

National Healthcare Properties (Ticker: NHP US) is a United States-based real estate investment trust specializing in senior housing and outpatient medical facilities. Incorporated in Maryland, the company focuses its operations on two primary segments: Senior Housing Operating Properties (SHOP) and Outpatient Medical Facilities (OMF).

National Healthcare Properties plans to list on the NASDAQ on April 22, 2026, offering 38.5 million shares at an estimated price range of $13.00 to $16.00 per share. Based on the $14.50 midpoint, the IPO is expected to raise approximately $558.25 million.

As of December 31, 2025, the company's portfolio reportedly consisted of 37 senior housing communities and 130 outpatient medical facilities located across 29 states. According to filings, the SHOP segment utilizes RIDEA structures, which expose the company to the direct operating performance of the facilities. The OMF segment primarily leases single-tenant and multi-tenant properties to healthcare providers. The IPO is being managed by a syndicate of underwriters, with Wells Fargo Securities, Morgan Stanley, BMO Capital Markets, Goldman Sachs, and RBC Capital Markets acting as lead joint managers.

Yesway, Inc. (Ticker: YSWY US) is an American company operating convenience stores across the Midwest and Southwest of the United States of America. Yesway plans to list on the NASDAQ on April 22, 2026, planning to offer 13,953,488 primary shares at a price range of $20.00 to $23.00, raising approximately $300 million.

According to sources, the company operates 449 stores across nine states, focusing on food service offerings, grocery selections, and private-label products. According to sources, the Fort Worth, Texas-headquartered company was established in 2015 and has expanded through strategic acquisitions and the recent development of 91 new stores.

Morgan Stanley, J.P. Morgan, and Goldman Sachs are acting as active bookrunners for the IPO, with Barclays, BMO, KeyBanc, Guggenheim, and Raymond James serving as passive bookrunners. Additionally, Morgan Stanley will reportedly serve as the stabilization agent and handle bill and deliver responsibilities. The management team is reportedly led by Chairman, CEO, and President Thomas N. Trkla alongside CFO and Treasurer Ericka L. Ayles.

Victory Giant Technology Huizhou Co Ltd (Ticker: 2476 HK) is a Chinese company specializing in advanced printed circuit boards for AI and high-performance computing. Victory Giant Technology plans to list on the Hong Kong Stock Exchange on April 21, 2026, offering 95.85 million shares at HKD 209.88 each, raising an offer size of HKD 20.12 billion (approximately USD 2.58 billion).

Victory Giant Technology reportedly plans to use the IPO proceeds for R&D and product capacity, brand promotion, business development, working capital, and strategic acquisitions. The company operates globally but is domiciled in China, structuring this transaction as an H Share listing.

According to the filing, the firm is holding a prominent global market share in circuit boards for AI servers and data centers, and manufactures complex, high-density interconnects. The IPO offering was upsized from an initial filing of 83.35 million shares and includes a 15 percent greenshoe facility. According to the prospectus, the transaction is managed by a syndicate of sponsors and underwriters, including J.P. Morgan Securities, GF Capital, and China Securities.

Kailera Therapeutics (Ticker: KLRA US) is an American advanced clinical-stage biotechnology company specializing in the development of obesity treatments. Kailera plans to list on the NASDAQ on April 17, 2026, planning to offer 33,333,334 primary shares at a price range of $14.00 to $16.00, raising approximately $500 million.

Reportedly, the company is progressing a diversified pipeline to provide therapeutic options for patients with obesity. Kailera is advancing four clinical-stage product candidates leveraging multiple GLP-1-based mechanisms of action and routes of administration. According to sources, the lead product candidate is ribupatide (KAI-9531), which targets weight loss. The pipeline also includes KAI-7535, a once-daily oral small molecule GLP-1 receptor agonist, and KAI-4729, a once-weekly injectable tri-agonist intended to target weight reduction and liver fat reduction.

According to sources, J.P. Morgan, Jefferies, Leerink, TD Cowen, and Evercore are acting as bookrunners for the IPO. Additionally, J.P. Morgan will serve as the stabilization agent and handle bill and deliver responsibilities. The management team is reportedly led by CEO and President Ron Renaud alongside CFO Douglas Pagan.

Alamar Biosciences, Inc. (Ticker: ALMR US) is an American company specializing in precision proteomics and advanced protein detection and analysis. Alamar Biosciences plans to list on the NASDAQ on April 17, 2026, planning to offer 9,375,000 primary shares at a price range of $15.00 to $17.00, raising approximately $150 million. According to sources, Alamar Biosciences plans to use the IPO proceeds for general corporate purposes, including working capital, operating expenses, and capital expenditures.

Reportedly, the company's proprietary NULISA technology and ARGO HT System enable ultra-high sensitivity and multiplexed biomarker analysis for early disease detection across discovery, translational research, and clinical diagnostics. The commercial-stage company generated total revenue of $74.2 million in 2025, which represents a 195% year-over-year growth. Founded in 2018 and headquartered in Fremont, California, the organization is currently led by Founder, Chairman, and CEO Yuling Luo alongside President Tod White. J.P. Morgan, Bank of America, and TD Cowen are reportedly acting as joint bookrunners for the IPO, with J.P. Morgan also serving as the stabilization agent and handling bill and deliver responsibilities.

Manycore Tech Inc (Ticker: 68 HK) is a China-based software company that provides cloud-native spatial design tools used for everything from home renovations to large commercial projects. Its primary software, Kujiale, uses artificial intelligence and advanced graphics processing to help designers create 3D visuals and automated manufacturing drawings. Manycore is the largest provider in China’s spatial design software market, and it also operates internationally under the brand Coohom.

The company is scheduled to list on the Hong Kong Stock Exchange on April 17, 2026. Manycore plans to offer 160.62 million shares within a price range of HKD 6.72 to HKD 7.62. This IPO aims to raise approximately HKD 1.22 billion (roughly $156.21 million USD), valuing the company between $1.46 billion and $1.66 billion USD.

According to its prospectus, Manycore intends to use the proceeds to fund research and development, expand its manufacturing capacity, and drive brand promotion and business growth. The company reported a significant financial turnaround recently, recording an adjusted net profit of RMB 57.1 million in 2025. The offering is being managed by J.P. Morgan, CCB International, and BOCI Asia.

AEVEX Corp. (Ticker: AVEX US) is a U.S. defense technology prime contractor specializing in autonomous unmanned systems and airborne intelligence, surveillance, and reconnaissance (ISR) solutions. The company designs and manufactures a diversified portfolio of battle-tested, modular Unmanned Aerial Systems (UAS) and Unmanned Surface Vehicles (USV), including loitering munitions and precision-strike products. AEVEX plans to list on the New York Stock Exchange (NYSE) on April 17, 2026, offering 16,000,000 primary shares at an expected price range of $18.00 to $21.00.

The IPO is expected to raise approximately $312 million, with the company targeting a market valuation of up to $2.35 billion. According to regulatory filings, AEVEX reportedly intends to use the proceeds to acquire units in its operating LLC, purchase shares from existing holders, and repay outstanding debt. Currently backed by private equity firm Madison Dearborn Partners and CoVant Management, the company operates under an "Up-C" structure rather than as a spin-off. AEVEX, which reported $433 million in revenue for 2025, serves a broad base of over 30 active customers across the U.S. Department of Defense and allied international partners. The offering is led by a bookrunning syndicate including Goldman Sachs, Bank of America, and Jefferies.

Gpixel Changchun Microelectronics Inc (Ticker: 3277 HK) is a China-based semiconductor company specializing in the research, design, and sale of high-performance CMOS image sensors (CIS). Operating under a fabless model, the company provides advanced imaging solutions for industrial, scientific, medical, and professional photography sectors. Gpixel is reportedly a global leader in its niche, ranking third in market share for both industrial and scientific imaging CIS revenue as of 2024. Gpixel plans to list on the Hong Kong Stock Exchange on April 17, 2026, offering 65.29 million shares at an IPO price of HKD 39.88.

The offering expects to raise approximately HKD 2.60 billion ($332.39 million USD), with a target market capitalization of roughly $1.5 billion USD. According to its prospectus, Gpixel reportedly plans to use the majority of the proceeds for research and development and expanding its product capacity. Remaining funds are earmarked for brand promotion, business development, working capital, and potential strategic acquisitions. The company operates as an H-share entity, and the offering is managed by joint sponsors CITIC Securities and Guotai Junan Capital.

Sigenergy Technology Co Ltd (Ticker: 6656 HK) is a China-based leader in the green energy sector, specializing in "all-in-one" energy storage systems for homes and businesses. Its main product, SigenStor, is a modular battery system that combines solar power, electric vehicle charging, and backup energy into one stackable unit. The company has grown rapidly since its 2019 founding, capturing a significant share of the global market across 85 countries.

Sigenergy is scheduled to list on the Hong Kong Stock Exchange on April 16, 2026. The company is offering 13.57 million shares priced at HKD 324.20 each, aiming to raise approximately HKD 4.40 billion (about $561.88 million USD). This puts the company’s estimated valuation at roughly $5.78 billion USD.

According to its filings, Sigenergy intends to use the money from the IPO to fund research and development, expand its manufacturing capacity, and grow its brand globally. The company operates as an H-share entity (a Chinese company incorporated in mainland China but listed in Hong Kong). The deal is being managed by major financial institutions including BNP Paribas, CITIC Securities, and CICC.

Arxis, Inc. (Ticker: ARXS US) is a United States-based company specializing in the design and manufacture of proprietary mission-critical electronic and mechanical components for extreme environments. The company serves the defense, space, commercial aerospace, medical technology, and industrial sectors. Arxis plans to list on the Nasdaq on April 16, 2026, offering 37.7 million shares at a price range of $25.00 to $28.00.

The IPO aims to raise approximately $1.06 billion, with a target market valuation of up to $11.2 billion. According to company filings, Arxis plans to use $750 million of the IPO proceeds to repay debt, reducing its total debt to approximately $1.9 billion. The company is a purpose-built platform created by sponsor Arcline Investment Management, having integrated over 30 acquisitions since its founding in 2019, including Kaman Corp. and Oldham Seals Group. Reported financials for 2025 show revenue of $1.6 billion and adjusted EBITDA of $571.3 million. Goldman Sachs, Morgan Stanley, and Jefferies are acting as joint bookrunners for the offering, which has reportedly secured $400 million in upfront commitments from cornerstone investors.

Madison Air Solutions Corp (Ticker: MAIR US) is an American company specializing in advanced indoor air purification and circulation systems. Serving commercial and residential markets, its portfolio spans single and multi-family homes, alongside commercial sectors including advanced manufacturing, data centers, education, healthcare and life sciences, hospitality and retail, indoor agriculture, industrial, institutional and government, logistics, and recreation. Madison Air plans to list on the NYSE on April 16, 2026, planning to offer 82.69 million shares between $25.00 and $27.00, raising up to $2.23 billion. The company would have an estimated market capitalization of about $12.7 billion.

According to sources, Goldman Sachs serves as the left lead underwriter, alongside Barclays, Jefferies, Wells Fargo, BofA Securities, Citigroup, and others. Madison Air's operations are anchored by a large installed base, with roughly half of its revenue driven by replacement and upgrade demand. For the year ended December 31, 2025, the company reportedly generated $3.3 billion in net sales and $124.3 million in net income, supported by a workforce of over 8,650 employees.

HMH Holding Inc. (Ticker: HMH US) is an American company specializing in highly engineered, mission-critical equipment solutions and services for the oil and gas drilling industry. HMH Holding plans to list on the NASDAQ on April 1, 2026, planning to offer 10.52 million shares at a price range of $19.00 to $22.00, raising up to $231 million. The company is targeting an estimated market capitalization of up to $948 million.

According to sources, the company operates as a joint venture formed in 2021 through the combination of the offshore drilling equipment units of Baker Hughes and Akastor, with each entity owning a 50 percent stake prior to the IPO. HMH Holding reportedly generates the majority of its revenue from aftermarket services and spare parts, recording $821.8 million in revenue and $46.1 million in net income for the 12 months ended December 31, 2025. According to reports, the firm's heritage brands trace their manufacturing roots back to 1895, and the company is proceeding with its public listing amid strong investor demand for energy sector issuers.

Shanghai FourSemi Semiconductor Co Ltd (Ticker: 3625 HK) is a China-domiciled fabless semiconductor company specializing in the design of power amplifier audio chips and haptic drivers. The company's products are used to optimize audio quality and provide tactile feedback in consumer electronics and intelligent vehicles. According to Frost & Sullivan, FourSemi ranked fourth globally among power amplifier audio chip providers by revenue in 2024. The company plans to list on the Main Board of the Hong Kong Stock Exchange on March 31, 2026.

The company is offering 12.00 million H shares at an expected price range of HKD 40.00 to HKD 50.00, aiming to raise approximately HKD 600.00 million (equivalent to USD 76.59 million). Based on this price range, the company’s estimated market capitalization is between USD 572 million and USD 715 million. According to the prospectus, the proceeds will be used for research and development, enhancing production capacity, brand promotion, business development, working capital, and strategic acquisitions. The offering is sponsored by Orient Capital and Guotai Junan Capital, with an underwriting syndicate including ABCI Capital, CCB International, and Futu Securities. Led by founder Xu Xiaolin, the company reportedly introduced China's first automotive-grade AEC-Q100-certified power amplifier audio chip in 2023.

Hangzhou Tongshifu Cultural & Creative Group Co Ltd (Ticker: 664 HK) is a China-domiciled company specializing in copper-based cultural and creative products. The company integrates traditional techniques with modern design to produce crafts, licensed toys, and artworks, expanding its portfolio to include gold, silver, and plastic materials. According to Frost & Sullivan, Tongshifu ranked first in China’s copper-based cultural and creative crafts market by revenue in 2024, holding a 35.0% market share. The company plans to list on the Main Board of the Hong Kong Stock Exchange on March 31, 2026.

Tongshifu is offering 7.41 million H shares at an expected price range of HKD 60.00 to HKD 68.00, aiming to raise approximately HKD 503.66 million (equivalent to USD 64.29 million). Based on this price range, the company’s estimated market capitalization is between USD 493 million and USD 558 million. According to the prospectus, the proceeds will be used for research and development, expanding production capacity, brand promotion, business development, working capital, and strategic acquisitions. The offering is sponsored by CMB International, with an underwriting group including ABCI Capital, CLSA, and Futu Securities.

Shandong Extreme Vision Technology Co Ltd (Ticker: 6636 HK) is a China-domiciled artificial intelligence company specializing in computer vision solutions. The company provides end-to-end development, deployment, and management services, including commercially viable large model solutions designed to facilitate digital transformation for enterprises. According to Frost & Sullivan, it ranked eighth in China’s emerging enterprise computer vision solution market by revenue in 2024. Extreme Vision plans to list on the Main Board of the Hong Kong Stock Exchange on March 30, 2026.

The company priced its IPO on March 20, 2026, offering 12.48 million H shares at HKD 40.00 per share, raising approximately HKD 499.20 million (equivalent to USD 63.72 million). At the offer price, the company’s market capitalization is reportedly USD 573.67 million. According to company filings, the proceeds are intended for research and development, expanding production capacity, brand promotion, business development, working capital, and strategic acquisitions. The offering is sponsored by CITIC Securities, with an underwriting group including ABCI Capital, CLSA, and CMB International. Institutional cornerstone investors reportedly include Zhengjin (Hong Kong) International and George Kent International.

Guangdong Huayan Robotics Co Ltd (Ticker: 1021 HK) is a China-domiciled collaborative robotics company specializing in the development, manufacturing, and sale of "cobots" and core motion components for industrial automation. The company provides high-precision hardware and an HRC Embodied Intelligence Control Platform for sectors including industrial manufacturing, consumer electronics, healthcare, and automotive logistics. Huayan Robotics plans to list on the Main Board of the Hong Kong Stock Exchange on March 30, 2026.

The company is offering 80.79 million H shares at an IPO price of HKD 17.00, raising approximately HKD 1.37 billion (equivalent to USD 175.31 million). Based on the offer price, the company’s market capitalization is reportedly USD 1.11 billion. According to the prospectus, Huayan Robotics intends to use the IPO proceeds for research and development, expanding production capacity, brand promotion, business development, working capital, and potential strategic acquisitions. The offering is managed by China International Capital Corporation, Deutsche Bank, Futu Securities, and Zheshang International. Institutional cornerstone investors reportedly include HHLR Advisors and GF Management, each contributing USD 30 million, alongside Morgan Stanley and others.

EpiWorld International Co Ltd (Ticker: 2726 HK) is a China-domiciled semiconductor company specializing in silicon carbide (SiC) epitaxial wafers. These wafers are advanced substrates layered with high-purity crystalline film, enabling power electronics to operate at higher voltages and temperatures than traditional silicon. As a global leader with a reported 2024 market share exceeding 30%, the company serves major power device providers for EVs, renewable energy, and AI computing. EpiWorld International plans to list on the Hong Kong Stock Exchange on March 30, 2026.

The company priced its IPO on March 27, 2026, offering 21.49 million H shares at HKD 76.26 each, raising approximately HKD 1.64 billion (USD 209.22 million). The offer price implies a market capitalization of USD 4.14 billion. According to the prospectus, proceeds are earmarked for R&D, production capacity expansion, working capital, and strategic acquisitions. Sponsored by China International Capital Corporation and joined by underwriters like ABCI Capital and CCB International, the firm was reportedly the first in China to commercialize 8-inch SiC epitaxial wafers under the leadership of founder Dr. Zhao Jianhui.

Hangzhou Diagens Biotechnology Co Ltd (Ticker: 2526 HK) is a China-domiciled medical device company specializing in the development of medical imaging products and services. The company’s primary focus is its core product, AI AutoVision, an auxiliary diagnostic software designed for intelligent chromosome karyotyping analysis used in prenatal diagnosis and assisted reproduction. Diagens plans to list its H shares on the Main Board of the Hong Kong Stock Exchange on March 30, 2026.

The company priced its IPO on March 27, 2026, offering 8.00 million shares at HKD 99.00 per share. The offering raised approximately HKD 792 million (equivalent to USD 101.09 million). At the offer price, the company’s market capitalization is reportedly USD 1.12 billion. According to the prospectus, Diagens intends to use the proceeds for research and development, enhancing production capacity, brand promotion, business development, working capital, and strategic acquisitions. The offering is sponsored by Huatai Financial Holdings, with a management group including ABCI Capital, BOCI Asia, and CCB International. The company's core technology has reportedly been recognized as a "Class III Innovative Medical Device" by the NMPA, allowing for an expedited regulatory path in China.

Beijing Tong Ren Tang Healthcare Investment Co Ltd (Ticker: 2667 HK) is a China-domiciled Traditional Chinese Medicine (TCM) healthcare provider and a subsidiary of the TRT Group. The company delivers a combination of medical treatment and care through a tiered network of 12 self-owned medical institutions, an Internet hospital, and 10 managed offline institutions. As of 2024, it is reportedly the largest TCM hospital group in China’s non-public TCM healthcare service industry by patient visits. Beijing Tong Ren Tang Healthcare plans to list on the Main Board of the Hong Kong Stock Exchange on March 30, 2026.

The company is offering 108.15 million shares with an expected price range of HKD 7.30 to HKD 8.30, aiming to raise approximately HKD 897.67 million (equivalent to USD 114.59 million). Based on the price range, the estimated market capitalization is between USD 435.5 million and USD 495.2 million. According to the prospectus, the proceeds will be used for brand promotion, business development, working capital, strategic acquisitions, and debt repayment. The IPO is sponsored by China International Capital Corporation, with a large underwriting syndicate including ABCI Capital and China Galaxy International.

Seiwa Holdings Co Ltd (Ticker: 523A JP) is a Japanese company specializing in promoting business succession in the manufacturing sector through group management and platform strategies. Seiwa Holdings plans to list on the Tokyo Stock Exchange on March 27, 2026, planning to offer 5,400,000 shares at a price of JPY 1,250 per share, raising an offer size of JPY 6.75 billion (USD 43.55 million). At the IPO price, the company will have an estimated market capitalization of USD 151.66 million.

According to sources, the IPO includes 3,720,000 primary shares and 1,680,000 secondary shares, with an additional greenshoe facility of 810,000 shares. Reportedly, the company's President, Yudai Nomiyama, is participating as a selling private investor, offering 200,000 shares. The managers of the offering include SBI Securities Co Ltd and Mizuho Securities Co Ltd. Seiwa Holdings focuses on solving the succession crisis in small and medium-sized manufacturing enterprises by acquiring them and integrating them into a comprehensive manufacturing network.

General Oceans ASA (Ticker: GENO NO) is a Norwegian holding company operating in the underwater technology sector, focusing on sonar, imaging, robotics, and data collection. Formed in 2021, the group unites several established brands, including Nortek, Strategic Robotic Systems, Reach Robotics, Tritech, Klein, and RS Aqua. General Oceans plans to list on Euronext Oslo Bors on March 26, 2026, planning to offer 50,000,000 shares at a price of NOK 21.00 per share, raising an offer size of NOK 1.05 billion (USD 108.99 million). At the IPO price, the company will reportedly have a pre-money equity value of NOK 3.44 billion.

According to sources, the IPO comprises a primary share issue of approximately NOK 500 million alongside a secondary offering by existing shareholders, including founder Atle Lohrmann and Ferd. General Oceans plans to use the IPO proceeds to support sustained organic growth and provide financial capacity for future acquisitions. Reportedly, the offering includes a 15 percent greenshoe facility of 7,500,000 shares, and two cornerstone investors have committed to subscribing for NOK 400 million. The managers of the offering are ABG Sundal Collier ASA, Arctic Securities, and DNB Bank ASA.

Jiangsu New Vision Automotive Electronics Co Ltd (Ticker: 2632 HK) is a Chinese company operating in the automotive parts and equipment industry, focusing on Head-Up Display (HUD) solutions. The company plans to list on the Hong Kong Stock Exchange on March 24, 2026, offering 16.23 million H shares at an expected price range of HKD 42.00 to 48.00. The IPO is expected to raise approximately HKD 778.87 million (USD 99.47 million). The company has an estimated market capitalization between HKD 5.18 billion and HKD 5.92 billion.

According to sources, Jiangsu New Vision provides comprehensive HUD solutions primarily centered on CyberLens (windshield HUD) and CyberVision (augmented reality HUD), along with testing solutions and other visual technology initiatives. The company reportedly collaborates with automotive OEMs at the solution definition stage to provide immersive human-vehicle interactions and intelligent driving experiences. The company plans to use the IPO proceeds for R&D and product capacity, brand promotion and business development, working capital, and strategic acquisitions. The offering's sponsors are reportedly Haitong International Capital and CITIC Securities, with BOCI Asia, CLSA, Futu Securities International, and Patrons Securities acting as bookrunners.

Zhejiang Galaxis Technology Group Co Ltd (Ticker: 2729 HK) is a Chinese company operating in the industrial automation and robotics industry. Zhejiang Galaxis Technology expects to list on the Hong Kong Stock Exchange on March 24, 2026, offering 36.80 million H shares at an expected price range of HKD 16.40 to 20.40. The IPO is expected to raise approximately HKD 750.68 million (USD 95.87 million). The company has an estimated market capitalization between HKD 7.02 billion and HKD 8.73 billion.

Zhejiang Galaxis Technology is an intelligent intralogistics robotics provider offering a diverse range of robots centered on multi-directional shuttle robots (MSRs), autonomous mobile robots (AMRs), and conveying and sorting robots (CSRs). Its robotics portfolio covers core intralogistics functions, including storage, sorting, and transport, to provide flexible and scalable automation. According to the company's prospectus, it ranked fifth among comprehensive intelligent intralogistics robotics companies in China by revenue in 2024.

The company plans to use the IPO proceeds for R&D and product capacity, brand promotion and business development, working capital, and strategic acquisitions. CITIC Securities and Guotai Junan Capital are acting as joint sponsors.

Nsing Technologies Inc (Ticker: 2701 HK) is a Chinese company focused on platform-based integrated circuit (IC) design and lithium-ion battery anode materials. Nsing Technologies expects to list on the Hong Kong Stock Exchange on March 23, 2026, offering 95,000,000 shares at an expected price of HKD 10.80, raising HKD 1.03 billion (USD 131.06 million).

According to sources, the company plans to use the IPO proceeds for R&D and product capacity, brand promotion and business development, working capital and strategic acquisitions, and debt repayment. Nsing Technologies operates in the circuits industry, delivering control chips and system solutions for intelligent terminals across sectors like consumer electronics, industrial control, smart home, automotive electronics, and medical electronics. According to marketing material, the company ranked fifth among Chinese companies in the global platform-based microcontroller unit (MCU) market in terms of revenue in 2024. The offering managers reportedly include BOCOM International Securities, CLSA, Futu Securities International, Jinluo Securities, and SPDB International Capital, with CITIC Securities acting as the sole sponsor.

FS.COM (Ticker: 3355 HK) is a Chinese company operating as an online direct-to-consumer networking solution provider. FS.COM plans to list on the Hong Kong Stock Exchange on March 23, 2026, planning to offer 40,000,000 H shares at a price range of HKD 35.20 to HKD 41.60, reportedly raising up to HKD 1.66 billion (USD 212.56 million). The company has an estimated market capitalization between USD 1.80 billion and USD 2.13 billion.

According to sources, the company delivers scalable networking solutions, including high-performance equipment, operating systems, and cloud-based management platforms. The company reportedly serves over 500,000 customers globally, with a major business focus in the USA, supporting scenarios like high-performance computing, data centers, enterprise networks, and telecommunications.

FS.COM reportedly plans to use the IPO proceeds for R&D and product capacity, brand promotion and business development, working capital, strategic acquisitions, and other general purposes. According to sources, the joint sponsors for the offering include China Merchants Securities, China International Capital Corporation, and China Securities International.